Emergence of Amphiphilicity on Surfaces of Pure Cellulose Nanofibrils Directly Generated by Aqueous Counter Collision Process
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.4c00581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Tetsuo Kondo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8, Saiwaicho, Fuchu, Tokyo 183-8509, Japan. Hauptthemen laut MEDLINE: Cellulose, Nanofibers, Water, Hydrophobic and Hydrophilic Interactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8, Saiwaicho, Fuchu, Tokyo 183-8509, Japan.
- Forestry and Forest Products Research Institute (FFPRI), Matsunosato1, Tsukuba, Ibaraki 305-8687, Japan.
- JEOL Ltd., 1156, Nakagami, Akishima, Tokyo 196-0022, Japan.
- United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, 3-5-8, Saiwaicho, Fuchu, Tokyo 183-8509, Japan.
ORCID-Profile: Tetsuo Kondo
Zitieren
APA
Kondo, T., Kataoka, Y., Hatano, T., & Funada, R. (2024). Emergence of Amphiphilicity on Surfaces of Pure Cellulose Nanofibrils Directly Generated by Aqueous Counter Collision Process. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c00581
Vancouver
Kondo T, Kataoka Y, Hatano T, Funada R. Emergence of Amphiphilicity on Surfaces of Pure Cellulose Nanofibrils Directly Generated by Aqueous Counter Collision Process. Biomacromolecules. 2024. doi:10.1021/acs.biomac.4c00581
BibTeX
@article{Kondo2024,
author = {Kondo, Tetsuo and Kataoka, Yutaka and Hatano, Tomohiro and Funada, Ryo},
title = {Emergence of Amphiphilicity on Surfaces of Pure Cellulose Nanofibrils Directly Generated by Aqueous Counter Collision Process},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.4c00581}
}
EUVIMED